K. Komamura et al., ECTO-5'-NUCLEOTIDASE MEDIATES INFARCT SIZE-LIMITING EFFECT BY ISCHEMIC PRECONDITIONING IN THE RABBIT HEART, Journal of cardiovascular pharmacology, 30(6), 1997, pp. 775-783
We examined whether ecto-5'-nucleotidase mediates infarct limitation b
y ischemic preconditioning in the rabbit heart. Ecto-5'-nucleotidase a
ctivity in ischemic region after ischemic preconditioning, was greater
than that in nonischemic regions (23.6 +/- 2.5 vs. 13.6 +/- 1.0 nmol/
mg protein/min; p < 0.01). With an inhibitor of 5'-nucleotidase, alpha
,beta-methylene adenosine 5'-diphosphate (AMP-CP), ecto-5'-nucleotidas
e activity in the ischemic region was comparable to that in the nonisc
hemic region. Mean blood pressure was reduced from 73 +/-: 2 to 62 +/-
+/- 3 mm Hg with intravenous AMP, whereas it did not change with cope
rfusion of AMP and AMP-CP, suggesting effective inhibition of ecto-5'-
nucleotidase. Separately, myocardial infarction was created by 30-min
coronary occlusion and 3 h of reperfusion. Infarct size expressed as p
ercentage volume in risk area was reduced by ischemic preconditioning
compared with that in the control (7.8 +/- 2.5% vs. 38.1 +/- 4.0%; p <
0.01), However, infarct size in the group given AMP-CP plus ischemic
preconditioning was similar to that in the control (36.2 +/- 2.8% vs.
38.1 +/-: 4.0%; NS), suggesting that ecto-5'-nucleotidase mediates inf
arct limitation by ischemic preconditioning in the rabbit.